Bears Eye KaloBios Pharmaceuticals Inc (KBIO) As Shkreli Gets the Boot

With the shares still halted, KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) boots CEO Martin Shkreli

by Josh Selway

Published on Dec 21, 2015 at 11:25 AM

While shares of KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) remain halted for the third straight day, the company has still landed in the spotlight. The firm just made public that it removed CEO Martin Shkreli on Thursday, following his arrest for securities fraud -- which he blamed on a government witch hunt. The company also announced that Shkreli gave up his spot on the firm's board.

After closing last Thursday at $23.59, KBIO was on the verge of losing half its value before being halted before the open on Friday. When the shares begin trading again, short sellers will be waiting with open arms, as short interest has been increasing steadily on the stock in recent weeks, more than doubling during the past reporting period. 

It's been a wild quarter for the biotech stock. KaloBios Pharmaceuticals Inc was trending lower for over two years, before skyrocketing in November when Shkreli became its largest shareholder and CEO. As such, the stock has added an astonishing 1,135% during the quarter, but could be near single-digit territory once trading resumes. 

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.
Google Postpones Android Reveal, "Now is Not the Time to Celebrate"
"Now is not the time to celebrate," Google said in a message on its website
ZNGA Zooms to 8-Year High on Billion-Dollar Deal
ZNGA is planning to buy Peak for $1.8 billion
Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....